⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

Guillain-Barre syndrome

7,685 total reports76.0% serious outcomes

7,685

Total Reports

199

Deaths

5,643

Hospitalizations

Severity Rate

% serious outcomes

About Guillain-Barre syndrome Reports

Guillain-Barre syndrome has been reported 7,685 times in VAERS from 1990 to 2026.

Of these reports, 199 were associated with death (2.59%) and 5,643 involved hospitalization.

The overall serious outcome rate (death or hospitalization) for reports mentioning Guillain-Barre syndrome is 76.0%.

Understanding Guillain-Barre syndrome in VAERS

•Temporal association only: These reports show Guillain-Barre syndrome occurred after vaccination, not necessarily because of vaccination.

•Background rates matter: Many symptoms occur naturally at baseline rates in the population, unrelated to vaccination.

•Reporting variability: Medical terminology may be used differently by various healthcare providers and over time.

•Investigation needed: High-frequency reports may trigger further epidemiological studies to determine causation.

What This Data Shows

Most Associated Vaccines: The vaccines most frequently mentioned in reports with Guillain-Barre syndrome. This may reflect usage patterns, not causation.

Severity Patterns: The percentage of reports that involve serious outcomes can help prioritize safety investigations.

Reporting Trends: Changes in reporting frequency over time may reflect increased awareness, media attention, or actual safety signals.